Primer Hiperparatiroidide Tc-99m MİBİ ile Yapılan Sintigrafik Görüntüleme Sonuçlarının İncelenmesi ve Biyokimyasal Parametreler ile İlişkisinin Değerlendirilmesi

Yeni tanı primer hiperparatiroidili (PHPT) hastalarda Teknesyum-99m MIBI ile yapılan sintigrafik görüntüleme yöntemi ile klinik, laboratuvar ve histopatolojik bulgular arasındaki ilişki retrospektif olarak incelenmiş, biyokimyasal ve histopatolojik parametrelerin sintigrafik lezyon tespitindeki rolünün değerlendirilmesi amaçlanmıştır. 2012-2018 yılları arasında paratiroid sintigrafisi için başvurmuş 516 hiperparatiroidili hasta dosyası retrospektif olarak tarandı. Hastalardan PHPT tanısı almış ve ilk defa paratiroidektomi uygulanmış 105 (94 kadın, 11 erkek) hasta dosyası çalışmaya dahil edilerek laboratuvar, ultrason (USG) ve klinik bulgular kaydedildi. Sintigrafik olarak paratiroid dokusu lokalize edilebilenler MIBI-pozitif (n=92) ve edilemeyenler MIBI-negatif (n=13) olarak iki grupta incelendi. USG ve sintigrafi yönteminin ve kombinasyonlarının duyarlılıkları ve tanısal doğruluğu değerlendirildi. MIBI-pozitif hastalarda kalsiyum değeri (11,48±0,75 mg/dl), MIBI-negatif olan gruba göre (11±0,68 mg/dl) anlamlı olarak yüksekti (p=0,047). USG’nin lezyon saptamadaki duyarlılığı %60,2, sintigrafinin %89,1 iken iki yöntemin kombinasyonunda duyarlılık %91,9 olarak saptandı. Sintigrafi tek başına kullanıldığında tanısal keskinlik %87,6 iken USG+sintigrafide %92 olarak saptandı. Paratiroid adenom boyutu ile PTH ve ALP arasında pozitif yönde anlamlı korelasyon saptandı (sırasıyla, p

Association of Tc99m-MIBI Scintigraphy and Biochemical Parameters in Primary Hyperparathyroidism

It was aimed to evaluate the relationship between clinical, laboratory, and histopathological findings with the scintigraphy performed with Technetium-99m MIBI in patients with primary hyperparathyroidism (PHPT). 516 patients who applied for parathyroid scintigraphy between 2012-2018 were retrospectively scanned. Files of 105(94 female, 11 male) patients, which were diagnosed as PHPT, were included in the study and laboratory, ultrasonography (USG), and findings were recorded. The scintigraphically parathyroid tissues that can be localized were examined in two groups as MIBI-positive(n=92) and those that could not be MIBI-negative (n=13). Sensitivity and diagnostic accuracy of USG and scintigraphy and combinations were evaluated. The calcium value (11.48±0.75 mg/dl) in MIBI-positive group was higher than MIBI-negative group (11±0.68 mg/dl) (p=0.047). While the sensitivity of USG in lesion detection was 60.2%, and scintigraphy was 89.1%, the sensitivity in the combination of the those was 91.9%. Diagnostic acuity of scintigraphy was 87.6%, USG+scintigraphy was 92%. A positive correlation was found between parathyroid adenoma size and PTH and ALP (p

PDF

___

1. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ, 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015;73:1-7.
2. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993- 2001: an update on the changing epidemiology of the disease. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2006;21:171-7.
3. Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. The Journal of clinical endocrinology and metabolism. 2013;98:1122-9.
4. Ruda JM, Hollenbeak CS, Stack BC, Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2005;132:359-72.
5. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis international : a journal established as result of cooperati on between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2017;28:1-19.
6. Sullivan DP, Scharf SC, Komisar A. Intraoperative gamma probe localization of parathyroid adenomas. The Laryngoscope. 2001;111:912-7.
7. Wojtczak B, Syrycka J, Kaliszewski K, Rudnicki J, Bolanowski M, Barczynski M. Surgical implications of recent modalities for parathyroid imaging. Gland surgery. 2020;9:S86-S94.
8. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, et al. SNM practice guideline for parathyroid scintigraphy 4.0. Journal of nuclear medicine technology. 2012;40:111-8.
9. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Annals of internal medicine. 1991;114:593-7.
10. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. The Journal of clinical endocrinology and metabolism. 2014;99:3561-9.
11. Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. European journal of nuclear medicine and molecular imaging. 2009;36:1201-16.
12. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. Jama surgery. 2016;151:959-68.
13. Wong KK, Fig LM, Gross MD, Dwamena BA. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nuclear medicine communications. 2015;36:363-75.
14. Aygün N İA, Uludağ M. Primer Hiperparatiroidili Hastalarda Preoperatif Ultrasonografi ve Sintigrafinin İlk Görüntülemede Patolojik Bezin Lokalizasyonunda Etkinliği. The Medıcal Bulletın Of Sıslı Etfal Hospıtal. 2019;4:379-84.
15. Çolakoğlu B AD. Diagnostic Value of Ultrasound and Tc-99m MIBI scintigraphy and SPECT/CT for Pre-operative Localization of Parathyroid Adenoma in Patients with Primary Hyperparathyroidism: A Single-Center Comparative Study. Jarem. 2019;3:115-20.
16. Qiu ZL, Wu B, Shen CT, Zhu RS, Luo QY. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables. Annals of nuclear medicine. 2014;28:725-35.
17. Ciappuccini R, Morera J, Pascal P, Rame JP, Heutte N, Aide N, et al. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clinical nuclear medicine. 2012;37:223-8.
18. Parikshak M, Castillo ED, Conrad MF, Talpos GB. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. The American surgeon. 2003;69:393-8; discussion 9.
19. Mshelia DS, Hatutale AN, Mokgoro NP, Nchabaleng ME, Buscombe JR, Sathekge MM. Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism. Clinical physiology and functional imaging. 2012;32:19-24.
20. Im HJ, Lee IK, Paeng JC, Lee KE, Cheon GJ, Kang KW, et al. Functional evaluation of parathyroid adenoma using 99mTc-MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity. Nuclear medicine communications. 2014;35:649-54.
21. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. The New England journal of medicine. 1999;341:1249-55.
22. Yamashita H, Noguchi S, Uchino S, Watanabe S, Koike E, Murakami T, et al. Vitamin D status in Japanese patients with hyperparathyroidism: seasonal changes and effect on clinical presentation. World journal of surgery. 2002;26:937-41.
23. Einollahi B TM, Motalebi M, Ramezani-Binabaj M. Normal alkaline phosphatase level in a patient with primary hyperparathyroidism due to parathyroid adenoma. Journal of parathyroid disease. 2014;1:47-50.
24. Fogelman I, Bessent RG, Beastall G, Boyle IT. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. Annals of internal medicine. 1980;92:65-7.
25. Lo CY, Lang BH, Chan WF, Kung AW, Lam KS. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. American journal of surgery. 2007;193:155-9.
26. Hwang-Bo Y, Kim JH, An JH, Hong ES, Ohn JH, Kim EK, et al. Association of the Parathyroid Adenoma Volume and the Biochemical Parameters in Primary Hyperparathyroidism. Endocrinol Metab. 2011;26:62-6.
27. De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, et al. Effect of gender and geographic location on the expression of primary hyperparathyroidism. Journal of endocrinological investigation. 2013;36:123-6.
28. 28. Cordes M, Dworak O, Papadopoulos T, Coerper S, Kuwert T. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocrine research. 2018;43:141-8.
29. 29. Prabhu M, Damle NA. Fluorocholine PET Imaging of Parathyroid Disease. Indian journal of endocrinology and metabolism. 2018;22:535-41.
30. 30. Taywade SK, Damle NA, Behera A, Devasenathipathy K, Bal C, Tripathi M, et al. Comparison of 18F-Fluorocholine Positron Emission Tomography/Computed Tomography and Four-dimensional Computed Tomography in the Preoperative Localization of Parathyroid Adenomas-initial Results. Indian journal of endocrinology and metabolism. 2017;21:399-403.
31. 31. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbeck’s archives of surgery. 2016;401:925-35.
27. De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, et al. Effect of gender and geographic location on the expression of primary hyperparathyroidism. Journal of endocrinological investigation. 2013;36:123-6.
28. Cordes M, Dworak O, Papadopoulos T, Coerper S, Kuwert T. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocrine research. 2018;43:141-8.
29. Prabhu M, Damle NA. Fluorocholine PET Imaging of Parathyroid Disease. Indian journal of endocrinology and metabolism. 2018;22:535-41.
30. Taywade SK, Damle NA, Behera A, Devasenathipathy K, Bal C, Tripathi M, et al. Comparison of 18F-Fluorocholine Positron Emission Tomography/Computed Tomography and Four-dimensional Computed Tomography in the Preoperative Localization of Parathyroid Adenomas-initial Results. Indian journal of endocrinology and metabolism. 2017;21:399-403.
31. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, et al. Use of PET tracers for parathyroid localization: a systematic review and metaanalysis. Langenbeck's archives of surgery. 2016;401:925-35.